期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 126, 期 5, 页码 881-887出版社
WILEY
DOI: 10.1002/jso.27079
关键词
adjuvant chemotherapy; colon cancer; minimally invasive surgery; neoadjuvant therapy; rectal cancer; screening
资金
- Berezuk Colorectal Cancer Research Fund
Although surgery has been the mainstay for treating colorectal cancer, advances in technology and clinical trials over the past 50 years have significantly expanded and improved the detection, staging, treatment, and understanding of this disease. This review highlights the contributions of surgeons, oncologists, gastroenterologists, engineers, and scientists in enhancing postsurgical survival, reducing treatment time and toxicity, and improving patients' quality of life over the past half-century.
Although surgery is the established standard and mainstay for treatment of colorectal cancer, advances in technology and clinical trials over the past 50 years have dramatically expanded and improved the detection, staging, treatment, and understanding of this disease. This review highlights contributions by surgeons, oncologists, gastroenterologists, engineers, and scientists to increase postsurgical recurrence-free survival, reduce the time and toxicity of treatment, and improve the quality of life for patients over the past half-century.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据